A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
ConditionMultiple Myeloma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione EMN Italy Onlus
About this trial
The aim of this observational study is the creation of a national multiple myeloma registry to monitor the current routine clinical practice in Italy and describe the standard of care adopted for the diagnosis and treatment of patients with multiple myeloma in the different Italian hematology centers.
Eligibility criteria
Qualifiers
Patients of both sexes
Age ≥ 18 years
Diagnosis of active/symptomatic multiple myeloma (according to CRAB and biological parameters) no earlier than 1st January 2019
Able and willing to sign an informed consent form
Disqualifiers
None considered
Trial design
Treatments tested in this trial
- Observation
Treatment groups
1,900 Participants
are divided into 1 treatment groupSponsors and collaborators
Fondazione EMN Italy Onlus
Lead sponsor
Amgen
Collaborator
GlaxoSmithKline
Collaborator
Janssen-Cilag S.p.A.
Collaborator
Sanofi
Collaborator
Takeda
Collaborator
Bristol-Myers Squibb
Collaborator
Source ClinicalTrials.gov